PUBLISHER: QYResearch | PRODUCT CODE: 1052163
PUBLISHER: QYResearch | PRODUCT CODE: 1052163
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
Market Analysis and Insights: Global Gastrointestinal OTC Drugs Market
Due to the COVID-19 pandemic, the global Gastrointestinal OTC Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Laxatives accounting for % of the Gastrointestinal OTC Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Gastrointestinal OTC Drugs market size is valued at US$ million in 2021, while the US and Europe Gastrointestinal OTC Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gastrointestinal OTC Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Gastrointestinal OTC Drugs include GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Gastrointestinal OTC Drugs Scope and Segment
Gastrointestinal OTC Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Gastrointestinal OTC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Segment by Application
By Company
By Region